Publicaciones en las que colabora con Salvador Resino García (80)

2024

  1. Plasma metabolomic profile is near-normal in people with HIV on long-term suppressive antiretroviral therapy

    Frontiers in Cellular and Infection Microbiology, Vol. 14

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Corrigendum to “PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study” [Biomed. Pharmacother. 159 (2023) 114220] (Biomedicine & Pharmacotherapy (2023) 159, (S0753332223000082), (10.1016/j.biopha.2023.114220))

    Biomedicine and Pharmacotherapy

  3. Diagnostic Performance of the HCV Core Antigen Test To Identify Hepatitis C in HIV-Infected Patients: a Systematic Review and Meta-Analysis

    Journal of clinical microbiology, Vol. 61, Núm. 1, pp. e0133122

  4. Diagnostic performance of hepatitis C core antigen assay to identify active infections: A systematic review and meta-analysis

    Reviews in Medical Virology, Vol. 33, Núm. 3

  5. IL7RA rs10491434 polymorphism is related to spontaneous HIV infection control in naïve HIV-infected patients: A retrospective study

    Journal of Medical Virology, Vol. 95, Núm. 11

  6. IRF5-TNOP3 polymorphisms are associated with elite control of HIV infection: A retrospective study

    Journal of medical virology, Vol. 95, Núm. 6, pp. e28841

  7. Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk

    Immunity and Ageing, Vol. 20, Núm. 1

  8. PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study

    Biomedicine and Pharmacotherapy, Vol. 159

  9. Predictive plasma biomarkers of long-term increase in hepatic steatosis index after HCV eradication in HIV/HCV-coinfected patients

    Biomedicine and Pharmacotherapy, Vol. 164

  10. Relative telomere length impact on mortality of COVID-19: Sex differences

    Journal of Medical Virology, Vol. 95, Núm. 1

  11. TNFAIP3-interacting protein 1 polymorphisms and their association with symptomatic human respiratory syncytial virus infection and bronchiolitis in infants younger than one year from South Africa: A case-control study

    International Journal of Infectious Diseases, Vol. 136, pp. 107-110

2022

  1. Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 3, pp. 719-726

  2. CEACAM7 polymorphisms predict genetic predisposition to mortality in post-surgical septic shock patients

    Journal of Microbiology, Immunology and Infection, Vol. 55, Núm. 3, pp. 540-544

  3. HCV eradication with DAAs differently affects HIV males and females: A whole miRNA sequencing characterization

    Biomedicine and Pharmacotherapy, Vol. 145

  4. IL-1R1 rs6755229 polymorphism is related to death in patients undergoing major surgery who develop septic shock: a retrospective study

    Infectious Diseases

  5. Meta-analysis: diagnostic accuracy of hepatitis C core antigen detection during therapy with direct-acting antivirals

    Alimentary Pharmacology and Therapeutics, Vol. 56, Núm. 8, pp. 1224-1234

  6. Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation

    Frontiers in Immunology, Vol. 13

  7. Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients

    Biomedicine and Pharmacotherapy, Vol. 147

  8. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806